Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®
Clinical trial NCT06587451 · TERMINATED
Trial details
- NCT number
- NCT06587451
- Sponsor
- Sandoz
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-19
- Primary completion
- 2026-01-23
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.